0.12 AUD
0
0%
Last update Dec 16, 10:00 AM AEDT
Market closed
Day range
0.12
0.12
Previous close
0.12000000
Open
0.12
Access this stock data via API
Subscribe
Invex Therapeutics Limited
0.12
0
0%

Statistics

Valuation metrics
Market cap
9.02M
Enterprise value
3.64M
Trailing P/E (ttm)
Forward P/E
PEG ratio
Price/Sales (ttm)
39.37
Price/Book (mrq)
1.71
Enterprise Value/Revenue
15.90
Enterprise Value/EBITDA
-3.83
Overview
Shares outstanding
75.15M
Float
45.68M
Shares short
% Held by insiders
63.93%
% Held by institutions
0
Average volume (10 days)
58.51K
Average volume (90 days)
47.23K
Price summary
52-Week low
0.06
52-Week high
0.18
52-Week change
38.33 64,971.2%
Beta
0.13
50-Day moving average
0.13
200-Day moving average
0.10
Financials
Fiscal year
Fiscal year ends
Jun 30, 2025
Most recent quarter (mrq)
Jun 30, 2025
Profitability
Profit margin
-208.16%
Operating margin
-103.51%
Operational effectiveness
Return on assets
-7.65%
Return on equity
-8.72%
Income statement
Revenue (ttm)
229.08K
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
-81.10%
Gross profit (ttm)
229.08K
EBITDA
0
Net income to common (ttm)
-476.87K
Diluted EPS (ttm)
-0.01
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
5.38M
Total cash per share (mrq)
0.07
Total debt (mrq)
0
Total Debt/Equity (mrq)
0
Current ratio (mrq)
2,478.70%
Book value per share (mrq)
0.07
Cash flow
Cash flow statement
-652.57K
Levered free cash flow (LFCF)
-635.87K
Access /statistics data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 14 hours 39 minutes

16:20
00:00
10:00
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
07:00 - 10:00
Main market
10:00 - 16:00
Post-market
16:00 - 16:12
All times are displayed in the Australia/Sydney timezone (AEDT, UTC+11:00).